- Home
- THAR vs TTNP Comparison
THAR vs TTNP Comparison
Compare THAR & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- TTNP
- Stock Information
- Founded
- THAR 2017
- TTNP 1991
- Country
- THAR United States
- TTNP United States
- Employees
- THAR N/A
- TTNP N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- THAR Health Care
- TTNP Health Care
- Exchange
- THAR Nasdaq
- TTNP Nasdaq
- Market Cap
- THAR 3.3M
- TTNP 3.4M
- IPO Year
- THAR 2022
- TTNP 1996
- Fundamental
- Price
- THAR $1.51
- TTNP $4.65
- Analyst Decision
- THAR Strong Buy
- TTNP
- Analyst Count
- THAR 1
- TTNP 0
- Target Price
- THAR $17.00
- TTNP N/A
- AVG Volume (30 Days)
- THAR 26.3K
- TTNP 81.0K
- Earning Date
- THAR 05-12-2025
- TTNP 05-14-2025
- Dividend Yield
- THAR N/A
- TTNP N/A
- EPS Growth
- THAR N/A
- TTNP N/A
- EPS
- THAR N/A
- TTNP N/A
- Revenue
- THAR N/A
- TTNP N/A
- Revenue This Year
- THAR N/A
- TTNP N/A
- Revenue Next Year
- THAR N/A
- TTNP N/A
- P/E Ratio
- THAR N/A
- TTNP N/A
- Revenue Growth
- THAR N/A
- TTNP N/A
- 52 Week Low
- THAR $0.95
- TTNP $3.03
- 52 Week High
- THAR $6.39
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- THAR 54.61
- TTNP 53.37
- Support Level
- THAR $1.41
- TTNP $4.16
- Resistance Level
- THAR $1.64
- TTNP $5.12
- Average True Range (ATR)
- THAR 0.11
- TTNP 0.44
- MACD
- THAR 0.01
- TTNP -0.01
- Stochastic Oscillator
- THAR 63.86
- TTNP 51.54
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.